2012
DOI: 10.1007/s11013-012-9249-z
|View full text |Cite
|
Sign up to set email alerts
|

Introduction to the Special Section: The Anthropology of Psychopharmaceuticals: Cultural and Pharmacological Efficacies in Context

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0
5

Year Published

2012
2012
2020
2020

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 13 publications
0
9
0
5
Order By: Relevance
“…Outside the emerging movement of personalized pharmacogenomics, psychiatry no longer has a ready-made individualizing modelVlike psychoanalysis of the 1950sVto address the complexity and the individuality of patient response. Indeed, much of the drug research today that addresses psychological and sociocultural variables has not come from within psychiatry but from anthropologists working outside psychiatry proper (Schlosser and Ninnemann, 2012). In addition, psychopharmaceutical development and testing today are intimately tied to their major source of funding, the pharmaceutical industry (Healy, 2002;Tobbell, 2011).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Outside the emerging movement of personalized pharmacogenomics, psychiatry no longer has a ready-made individualizing modelVlike psychoanalysis of the 1950sVto address the complexity and the individuality of patient response. Indeed, much of the drug research today that addresses psychological and sociocultural variables has not come from within psychiatry but from anthropologists working outside psychiatry proper (Schlosser and Ninnemann, 2012). In addition, psychopharmaceutical development and testing today are intimately tied to their major source of funding, the pharmaceutical industry (Healy, 2002;Tobbell, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…However, the narrow focus on rational targets in the body has resulted in practitioners losing sight of the larger psychosocial context in which drugs are taken (Greene et al, 2012). This historical examination of psychopharmacology illustrates the present-day need to socialize and contextualize interventions, such as pharmaceuticals, that are too often understood in a reductive biomedical framework (Schlosser and Ninnemann, 2012). The psychosocial pharmacology of the 1950s suggests an interdisciplinary path toward the (re)creation of a holistic model of drug response that acknowledges the biological, psychological, and sociocultural world in which drugs are embedded.…”
mentioning
confidence: 99%
“…Jenkins (2011) aponta que cerca de um quarto de adultos nos Estados Unidos da América utilizam algum medicamento psicoativo, incluso Ritalina e Concerta. Entretanto, esse quadro não é algo específico de tal país, sendo que se espalha por diversos países da Ásia, África e América do Sul (Rose, 2004;Schlosser & Ninneman, 2012). De acordo com o Ministério de Saúde e Proteção Social da Colômbia (2015), a prevalência do TDAH no país é de 3%, o que corresponde aproximadamente 317.665 casos.…”
Section: Apontamentos Acerca Da Infância Na Contemporaneidadeunclassified
“…Recent work in pharmaceutical anthropology (e.g., Schlosser and Ninnemann ) calls for the need to understand pharmaceutical efficacy in relation to the biological, sociological, and structural factors that shape individual responses to drugs. The cases discussed here reveal new fault lines through which the pharmakon exerts its influence, collapsing the distinctions between biological and sociological factors.…”
Section: Small Gaps Big Differencesmentioning
confidence: 99%